Abstract
Background: Tumor hypoxia induces hypoxiainducible factor-1α (HIF1α), which can influence tumorigenesis and metastasis. We evaluated the expression of HIF1α and the effect of HIF1α inhibitors in adenoid cystic carcinoma (ACC). Materials and Methods: HIF1α expression was demonstrated in ACC cell lines (ACC2 and ACCM). The effect of HIF1α inhibitors was evaluated. A systemic metastasis model was developed. The number of metastatic pulmonary nodules were analyzed. Results: The ACCM cell line demonstrated greater HIF1α expression and invasion than ACC2. The expression of HIF1α and invasion of ACC cells were blocked by HIF1α siRNA. HIF1α inhibitors 17-Nallylamino-17-demethoxygeldanamycin (17AAG) and echinomycin inhibited cell invasion. 17AAG inhibited metastasis in the animal model, although not statistically significantly. Conclusion: HIF1α siRNA and 17AAG and echinomycin blocked invasion by ACC2 and ACCM cells. 17AAG exhibited therapeutic potential for inhibition of metastasis. Our results provide positive evidence that HIF1α is a promising research pathway for therapy of ACC.
Author supplied keywords
Cite
CITATION STYLE
Lim, Y. S., Cha, W., Park, M. W., Jeong, W. J., & Ahn, S. H. (2017). HIF1α in tumorigenesis of adenoid cystic carcinoma. Anticancer Research, 37(2), 599–606. https://doi.org/10.21873/anticanres.11353
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.